HDP-102

N/A

Report date: 2024/02/05 14:02:36

Base Information

Drug NameHDP-102
Drug Alias NameAnti-CD37 antibody targeted amanitin conjugatesHDP-102CD37-ATAC
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Amanitin payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionRNA polymerase II inhibitorsLeukocyte antigen CD37 antagonists
TargetsRNA polymerase IILeukocyte antigen CD37
Therapy Area/IndicationsLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHeidelberg Pharma AG
China Registration ClassN/A

Develop Information

Active CompaniesHuadong Medicine Co LtdHeidelberg Pharma AG
Inactive CompaniesN/A
Active IndicationsLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A